Is laser treatment or surgery the best way of treating varicose veins?

ISRCTN ISRCTN99270116
DOI https://doi.org/10.1186/ISRCTN99270116
Secondary identifying numbers VS03/2281
Submission date
11/06/2007
Registration date
10/07/2007
Last edited
19/03/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Mr Michael Gough
Scientific

Leeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
LS1 3EX
United Kingdom

Study information

Study designParallel group, non-blinded, randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study hypothesisEndovenous laser ablation (EVLA) produces comparable short-term results to surgery (abolition of great saphenous vein [GSV] reflux and improvement in symptoms) for the treatment of primary varicose veins due to sapheno-femoral incompetence with greater saphenous vein reflux.
Ethics approval(s)Received from Leeds (West) Research Ethics Committee in May 2003 (ref: 03/052).
ConditionVaricose veins
InterventionEndovenous laser treatment (810 nm diode laser, Diomed) versus sapheno-femoral ligation, greater saphenous vein stripping and avulsions (surgery).
Intervention typeOther
Primary outcome measure1. Abolition of GSV reflux at three months (duplex ultrasound)
2. Improvement in disease-specific quality of life (Aberdeen Varicose Vein Questionnaire)
Secondary outcome measures1. Time to return to work and to normal activity
2. Pain and analgesia use during first week following treatment
3. Overall satisfaction and satisfaction with cosmetic outcome
4. Generic quality of life (36-item Short Form health survey [SF-36]) at 1 and 12 weeks following treatment
5. Complications
Overall study start date05/06/2003
Overall study end date01/12/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants342
Participant inclusion criteria1. Symptomatic varicose veins
2. Primary sapheno-femoral incompetence with greater saphenous vein reflux
Participant exclusion criteria1. Unable to consent
2. Children (under 18 years)
3. Unfit for general anaesthesia
4. Recurrent varicose veins
5. Patients on long-term anticoagulation
6. Patients with anterior thigh branch of greater saphenous vein arising within 10 cm of groin and competent GSV distal to this
Recruitment start date05/06/2003
Recruitment end date01/12/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Leeds Vascular Institute
Leeds
LS1 3EX
United Kingdom

Sponsor information

Leeds Teaching Hospitals NHS Trust (UK)
Hospital/treatment centre

Leeds Vascular Institute
The General Infirmary at Leeds
Great George Street
Leeds
LS1 3EX
England
United Kingdom

Website http://www.leedsteachinghospitals.com/
ROR logo "ROR" https://ror.org/00v4dac24

Funders

Funder type

Government

Leeds Teaching Hospitals NHS Trust (UK)

No information available

Diomed Ltd (UK) - part of research fellow salary paid (£15,000 pa)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/03/2008 Yes No